Long-term functional and psychological recovery in a population of acute respiratory distress syndrome patients treated with VV-ECMO and in their caregivers

2019 ◽  
Vol 85 (9) ◽  
Author(s):  
Filippo Sanfilippo ◽  
Mariachiara Ippolito ◽  
Cristina Santonocito ◽  
Gennaro Martucci ◽  
Tiziana Carollo ◽  
...  
2020 ◽  
Author(s):  
Sung Yoon Lim ◽  
Soyeon Ahn ◽  
Sang-Bum Hong ◽  
Chi Ryang Chung ◽  
Kyeongman Jeon ◽  
...  

Abstract Background Recirculation during veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a known drawback that limits sufficient oxygenation. This study aimed to compare the short-term oxygenation and long-term mortality based on cannula configuration in patients with acute respiratory distress syndrome (ARDS) who receive VV-ECMO, especially in the absence of newly developed double-lumen, single cannula.Methods Data of patients with severe ARDS who received VV-ECMO from 2012–2015 at six hospitals were retrospectively analyzed. Primary outcomes were the partial pressure of oxygen (PaO 2 ) at 1, 4, and 12 hours after ECMO initiation and 180-day mortality.Results Patients ( n = 354) were divided into two groups based on the return cannula site: femoral vein ( n = 193) or internal jugular vein ( n = 161). Baseline characteristics at admission, including PaO 2 , were similar between the groups. PaO 2 at 1 hour after ECMO initiation was higher in the femoral than in the jugular group (190.3 vs. 160, P = 0.108). No significant increase in PaO 2 occurred at 4 and 12 hours between the groups. PaCO 2 decrement at 4 hours was lower in the jugular than in the femoral group (36.4 vs. 33.7 mmHg, P = 0.009). The two groups did not differ in terms of mortality at 180 days after ECMO, however more cannula related complications occurred in the jugular group.Conclusion Regardless of the cannula configuration, patients with ARDS managed with VV-ECMO showed comparable clinical outcomes in terms of short-term oxygenation and long-term mortality. Nevertheless, further well-designed randomized control trials are warranted.


Perfusion ◽  
2018 ◽  
Vol 33 (5) ◽  
pp. 375-382 ◽  
Author(s):  
Richard Devasagayaraj ◽  
Nicholas C. Cavarocchi ◽  
Hitoshi Hirose

Introduction: Patients who develop severe acute respiratory distress syndrome (ARDS) despite full medical management may require veno-venous extracorporeal membrane oxygenation (VV ECMO) to support respiratory function. Survival outcomes remain unclear in those who develop acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) during VV ECMO for isolated severe respiratory failure in adult populations. Methods: A retrospective chart review (2010-2016) of patients who underwent VV ECMO for ARDS was conducted with university institutional review board (IRB) approval. Patients supported by veno-arterial ECMO were excluded. AKI was defined by acute renal failure receiving CRRT and the outcomes of patients on VV ECMO were compared between the AKI and non-AKI groups. Results: We identified 54 ARDS patients supported by VV ECMO (mean ECMO days 12 ± 6.7) with 16 (30%) in the AKI group and 38 (70%) in the non-AKI group. No patient had previous renal failure and the serum creatinine was not significantly different between the two groups at the time of ECMO initiation. The AKI group showed a greater incidence of complications during ECMO, including liver failure (38% vs. 5%, p=0.002) and hemorrhage (94% vs. 45%, p=0.0008). ECMO survival of the AKI group (56% [9/16]) was inferior to the non-AKI group (87% [33/38], p=0.014). Conclusions: Our study demonstrated that VV ECMO successfully manages patients with severe isolated lung injury. However, once patients develop AKI during VV ECMO, they are likely to further develop multi-organ dysfunction, including hepatic and hematological complications, leading to inferior survival.


Perfusion ◽  
2019 ◽  
Vol 34 (6) ◽  
pp. 523-525 ◽  
Author(s):  
Samuel M Galvagno ◽  
Nirav G Shah ◽  
Christopher R Cornachione ◽  
Kristopher B Deatrick ◽  
Michael A Mazzeffi ◽  
...  

Introduction: Diffuse alveolar damage is the histologic hallmark for the acute phase of acute respiratory distress syndrome and can occasionally present as diffuse alveolar hemorrhage. Case report: We report a patient with diffuse alveolar hemorrhage and acute respiratory distress syndrome requiring veno-venous extracorporeal life support for 210 days, who was successfully treated for a period of 130 consecutive days without intravenous anticoagulation. Discussion: Although there are a few brief reports detailing long extracorporeal life support runs, the literature is largely devoid of data regarding long-term extracorporeal life support without full systemic anticoagulation. Regular inspection of the extracorporeal membrane oxygenation circuit is critical because externally visible thrombi may predict internal thrombus generation with the potential for systemic embolization or abrupt oxygenator failure. In our case, multiple circuit and oxygenators changes were required. Conclusion: We have demonstrated that a patient with a contraindication for systemic anticoagulation can safely have veno-venous extracorporeal life support for prolonged periods without catastrophic thrombotic complications.


2017 ◽  
Vol 18 (1) ◽  
pp. e48-e55 ◽  
Author(s):  
Shan L. Ward ◽  
Autumn Turpin ◽  
Aaron C. Spicer ◽  
Marsha J. Treadwell ◽  
Gwynne D. Church ◽  
...  

2006 ◽  
Vol 34 (12) ◽  
pp. 2883-2890 ◽  
Author(s):  
Derek C. Angus ◽  
Gilles Clermont ◽  
Walter T. Linde-Zwirble ◽  
Amjad A. Musthafa ◽  
Tony T. Dremsizov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document